Ginkgo Bioworks Holdings, Inc.

NYSE (USD): Ginkgo Bioworks Holdings, Inc. (DNA)

Last Price

0.988

Today's Change

0.00 (0.00%)

Day's Change

0.00 - 0.00

Trading Volume

0

Overview

Market Cap

2 Billion

Shares Outstanding

2 Billion

Avg Volume

30,900,508

Avg Price (50 Days)

1.09

Avg Price (200 Days)

1.50

PE Ratio

-2.15

EPS

-0.46

Earnings Announcement

01-Mar-2024

Previous Close

0.95

Open

0.98

Day's Range

0.961 - 1.03

Year Range

0.74 - 2.545

Trading Volume

30,668,567

Price Change Highlight

1 Day Change

3.47%

5 Day Change

12.53%

1 Month Change

-8.51%

3 Month Change

-20.31%

6 Month Change

-35.84%

Ytd Change

-40.83%

1 Year Change

-27.88%

3 Year Change

-90.18%

5 Year Change

-90.24%

10 Year Change

-90.24%

Max Change

-90.24%

News and Blogs

No result.

Company Profile

Sector: Healthcare - Healthcare

Industry: Biotechnology

Description:

Ginkgo Bioworks Holdings, Inc., together with its subsidiaries, develops platform for cell programming. Its platform is used to program cells to enable biological production of products, such as novel therapeutics, food ingredients, and chemicals derived from petroleum. The company serves various end markets, including specialty chemicals, agriculture, food, consumer products, and pharmaceuticals. Ginkgo Bioworks has a partnership with Selecta Biosciences, Inc. to develop ImmTOR technology platform. Ginkgo Bioworks Holdings, Inc. was founded in 2008 and is headquartered in Boston, Massachusetts.

Discussions
Be the first to like this. Showing 0 of 0 comments

Post a Comment